Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma

Head Neck. 2006 Dec;28(12):1099-105. doi: 10.1002/hed.20479.

Abstract

Background: Our primary objective was to determine the role of neck dissection following concomitant chemoradiation (CRT) for advanced stage III-IV head and neck squamous cell carcinoma (HNSCC).

Methods: One hundred eighty-four patients with HNSCC treated with CRT were included. One hundred twenty-three patients reached a regional complete response (CR) after CRT and no neck dissection was performed. Forty-five patients among the 58 who reached a regional partial response (PR) underwent a neck dissection.

Results: Overall, regional CR rate after CRT was 68%. Patients who reached a regional CR (no neck dissection) had an overall neck recurrence rate of 5%. Patients with regional PR who underwent a neck dissection had a 7% neck recurrence rate.

Conclusions: Patients with regional CR not followed by a neck dissection have a low rate of neck recurrence. Systematic neck dissection is not mandatory for patients with nodes less than 6 cm reaching a regional CR. For patients with nodes larger than 6 cm, no firm recommendation can be given because of the small number of patients in this series. If the regional response is incomplete, cervical dissection is warranted.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy*
  • Combined Modality Therapy
  • Dose Fractionation, Radiation
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Male
  • Middle Aged
  • Neck Dissection*
  • Platinum Compounds / administration & dosage
  • Reproducibility of Results
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Platinum Compounds